Immune modulation as a consequence of SARS-CoV-2 infection

Area of Science:

• Immunology
• Infectious Diseases
• Pathogenesis

Background:

• COVID-19 pathogenesis involves complex immune dysregulation.
• Understanding immune network alterations is crucial for managing COVID-19.

Purpose of the Study:

• To investigate alterations in innate and adaptive immunity during COVID-19.
• To correlate immune changes with clinical disease severity.

Main Methods:

• Analysis of immune cell subsets (ILCs, NK, T cells, B cells) in 34 COVID-19 patients.
• Measurement of serum cytokine levels (TNF-α, IL-6, IL-8, IFN-γ, IL-10).
• Correlation analysis between immune markers and clinical parameters (D-dimer).

Main Results:

• Decreased ILC1, increased ILC2 in mild/moderate COVID-19.
• Reduced NK cell subsets and cytotoxicity in severe COVID-19.
• Diminished CD3+ and CD3+CD8+ T cells in severe cases, correlated with D-dimer.
• Elevated plasmablasts, plasma cells, IgG, and IgA in patients.
• Increased pro-inflammatory cytokines (TNF-α, IL-6, IL-8) and IL-10, with reduced IFN-γ in severe patients.

Conclusions:

• SARS-CoV-2 infection profoundly impacts both innate and adaptive immunity.
• Immune modulation differs based on COVID-19 clinical severity.
• Reduced T cells and elevated IL-10 in severe COVID-19 may be protective against cytokine storm.